Trastuzumab quantification in serum: a new, rapid, robust ELISA assay based on a mimetic peptide that specifically recognizes trastuzumab-Reference-Cited by-同舟云学术

Trastuzumab quantification in serum: a new, rapid, robust ELISA assay based on a mimetic peptide that specifically recognizes trastuzumab

Published:2014-05-15 Issue:18 Volume:406 Page:4557-4561
ISSN:1618-2642
Container-title:Analytical and Bioanalytical Chemistry
language:en
Short-container-title:Anal Bioanal Chem

Author:

Cardinali Barbara,Lunardi Gianluigi,Millo Enrico,Armirotti Andrea,Damonte Gianluca,Profumo Aldo,Gori Stefania,Iacono Giuseppina,Levaggi Alessia,Del Mastro Lucia

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry,Analytical Chemistry

Link

http://link.springer.com/content/pdf/10.1007/s00216-014-7842-4.pdf

Reference9 articles.

1. Eisenhauer EA (2001) From the molecule to the clinic-inhibiting HER2 to treat breast cancer. N Engl J Med 344(11):841–842

2. Leveque D, Gigou L, Bergerat JP (2008) Clinical pharmacology of trastuzumab. Curr Clin Pharmacol 3:51–55

3. Maple L, Lathrop R, Bozich S, Harman W, Tacey R, Kelley M, Danilkovitch-Miagkova A (2004) Development and validation of ELISA for Trastuzumab detection in human serum. J Immunol Meth 295(1–2):169–182

4. Damen CWN, de Groot ER, Heij M, Boss DS, Schellens JHM, Rosing HA, Beijnen JH, Aarden LA (2009) Development and validation of an enzyme-linked immunosorbent assay for the quantification of trastuzumab in human serum and plasma. Anal Biochem 391(2):114–120

5. Jiang B, Liu W, Qu H, Meng L, Song S, Ouyang T, Shou C (2005) A novel peptide isolated from a phage display peptide library with trastuzumab can mimic antigen epitope of HER-2. J Biol Chem 280(6):4656–4662

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid isolation of anti-idiotype aptamers for quantification of human monoclonal antibodies against SARS-CoV-2 spike protein;Biosensors and Bioelectronics;2024-02

2. A Double-blind Randomized Comparative Phase I Study to Assess Biosimilarity and Immunogenicity of "Trastuzumab" (LLC "Mabscale", Russia) and Herceptin® (F. Hoffmann-La Roche Ltd., Switzerland) in Healthy Volunteers;Drug development & registration;2023-09-01

3. Lipid Metabolism Reprogramming and Trastuzumab Resistance in Breast Cancer Cell Lines Overexpressing the ERBB2 Membrane Receptor;Membranes;2023-05-23

4. First Evidence of Anti-Steatotic Action of Macrotympanain A1, an Amphibian Skin Peptide from Odorrana macrotympana;Molecules;2022-11-01

5. Label‐Free Detection and Translocation Dynamics Study of Single‐Molecule Herceptin Using Solid‐State Nanopores;Advanced Materials Technologies;2022-05-31